rs75559353
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The ENST00000377075.3(CNNM4):c.2149C>T(p.Gln717Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q717Q) has been classified as Likely benign.
Frequency
Consequence
ENST00000377075.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNNM4 | NM_020184.4 | c.2149C>T | p.Gln717Ter | stop_gained | 7/7 | ENST00000377075.3 | NP_064569.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNNM4 | ENST00000377075.3 | c.2149C>T | p.Gln717Ter | stop_gained | 7/7 | 1 | NM_020184.4 | ENSP00000366275 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 249092Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134850
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461844Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727226
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change creates a premature translational stop signal (p.Gln717*) in the CNNM4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 59 amino acid(s) of the CNNM4 protein. This variant is present in population databases (rs75559353, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Jalili syndrome (PMID: 19200525). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2852). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation as the last 59 amino acids are lost, although loss-of-function variants have not been reported downstream of this position in the protein; Identified in a family with Jalili syndrome in the published literature (Parry DA et al., 2009); This variant is associated with the following publications: (PMID: 19200525, 28246031) - |
Jalili syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2009 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at